Pharmacoeconomics guidelines: The need of hour for India

Culyer, 2001, J Med Ethics, Economics and ethics in health care, 217

Malik AM. NICE international: Be nice to Pakistan. Electronic response to Chalkidou K, Levine R, Dillon A. Helping poorer countries make locally informed health decisions. BMJ 2010;341:c3651.

Hogerzeil, 2006, Bull World Health Organ, Essential medicines and human rights: What can they learn from each other?, 371

Perehudoff, 2010, Bull World Health Organ, Access to essential medicines in national constitutions, 800

High level expert group report on universal health coverage for India; 2011. Available from: http://www.planningcommission.nic.in/reports/genrep/rep_uhc0812.pdf. [Last accessed on 2014 Mar 09].

Sinha K. Free medicines for all from October. Article in Times of India, 2012. http://www. articles.timesofindia.indiatimes.com/2012-06-23/india/32381413_1_health-centres-essential-drugs-list-free-medicines. [Last accessed on 2014 Apr 09].

Evans, 2010, Bull World Health Organ, Health systems financing and the path to universal coverage, 402

The Millennium Development Goals Report. New York: United Nations; 2009. Available from: http://www.un.org/millenniumgoals/pdf/MDG_Report_2009_ENG.pdf. [Last accessed on 2014 Apr 09].

WHO. The World Medicines Situation. Geneva: World Health Organization; 2004. [Last accessed on 2014 April 09].

Organization for Economic Co-operation and Development. Drug spending in OECD countries up by nearly a third since 1998, according to new OECD data. Available from: http://www.oecd.org/document/25/0,2340,en_2649_37407_34967193_1_1_1_37407,00.htm. [Last accessed on 2014 Apr 09].

WHO. Equitable Access to Essential Medicines: A Framework for Collective Action. Geneva: World Health Organization; 2004. [Last accessed on 2014 Apr 09].

WHO Medicines Strategy 2004-2007. Geneva: World Health Organization; 2004. (WHO/EDM/2004.5). Available from: http://www.whqlibdoc.who.int/hq/2004/WHO_EDM_2004.5.pdf. [Last accessed on 2014 Jun 04].

McIntyre, 2006, Soc Sci Med, What are the economic consequences for households of illness and of paying for health care in low- and middle-income country contexts?, 858

Niëns, 2010, PLoS Med, Quantifying the impoverishing effects of purchasing medicines: A cross-country comparison of the affordability of medicines in the developing world, E1000333

Thatte, 2009, Value Health, Evidence-based decision on medical technologies in Asia Pacific: Experiences from India, Malaysia, Philippines, and Pakistan, S18

Health care in India: Emerging market report. Available from: http://www.pwc.com/en_GX/gx/healthcare/pdf/emerging-market-report-hc-in-india.pdf. [Last accessed on 2014 Jun 04].

Townsend, 1987, Drug Intell Clin Pharm, Postmarketing drug research and development, 134

Yang, 2009, Value Health, Growing application of pharmacoeconomics and outcomes research in health-care decision-making in the Asia-Pacific region, S1

Hass, 2012, Perspect Clin Res, Health technology assessment and its role in the future development of the Indian healthcare sector, 66

Cameron, 2009, Lancet, Medicine prices, availability, and affordability in 36 developing and middle-income countries: A secondary analysis, 240

Waning, 2009, Bull World Health Organ, Global strategies to reduce the price of antiretroviral medicines: Evidence from transactional databases, 520